Detecting type 2 diabetes by a single post-challenge blood sample

Clinical Chemistry and Laboratory Medicine

Volumn 41, Issue 9, 2003, Pages 1251-1258

  Haeckel, Rainer ^a   Wosniok, Werner ^b   Raber, Rüdiger ^a   Janka, Hans Uwe ^c  

^a Zentralkrankenhaus   (Germany)

^b UNIVERSITY OF BREMEN   (Germany)

^c Zentralkrankenhaus Bremen Nord   (Germany)

Author keywords

Diabetes mellitus; Glucose tolerance; Insulin resistance

Indexed keywords

GLUCOSE; INSULIN;

ADULT; AGED; CAPILLARY BLOOD; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; EARLY DIAGNOSIS; FEMALE; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RESPONSE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MEDICAL SOCIETY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; REVIEW; VENOUS BLOOD; WORLD HEALTH ORGANIZATION;

ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED;

ADA;

EID: 0142124818     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2003.192     Document Type: Review

References (68)

1. Harris MI. Undiagnosed NIDDM: clinical and public health issues. Diabetes Care 1993; 16:642-52.
2. DECODE study group. Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies. Diabetologia 1999; 42:647-54.
3. American Diabetes Association. Report of the Expert Committee on the Diagnosis and Classification of Diabetes mellitus. Diabetes Care 1997; 20:1183-97.
4. Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diab Med 1998; 15:539-53.
5. World Health Organization: WHO Study Group on Diabetes mellitus. Technical Report Series 727. Geneva, WHO, 1985.
6. World Health Organization. WHO Study Group on Prevention of Diabetes mellitus. Technical Report Series 844. Geneva, WHO, 1994.
7. Gomez SGA, Ferreira SRG, Franco LJ, Iunes M. Comparison of glucose tolerance categories according to World Health Organization and American Diabetes Association diagnostic criteria in a population-based in Brazil. Diabetes Care 1998; 21:1889-92.
8. Gomez-Perez FJ, Aguilar-Salinas CA, Lopez-Alvarenga, Perez-Jauregui J, Guillen-Pineda LE, Rull JA. Lack of agreement between the World Health Organization category of impaired glucose tolerance and the American Diabetes Association category of impaired fasting glucose. Diabetes Care 1998; 21:1886-8.
9. Richard JL, Vannereau D, Parer-Richard C. Impact of the new ADA diagnostic criteria for diabetes on an obese population: comparison with oGTT-based WHO criteria. Diabetes Metab 1998; 24:365-7.
10. Ramachandran A, Snehalatha C, Latha E, Vijay V. Evaluation of the use of fasting plasma glucose as a new diagnostic criterion for diabetes in Asian Indian population. Diabetes Care 1998; 21:666-7.
11. Mannucci E, Bardini G, Ognibene A, Rotella CM. Screening for diabetes in obese patients using the new diagnostic criteria. Diabetes Care 1998; 21:468.
12. Tuomiletho J, Borch-Johnsen K, Balkau B. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The Lancet 1999; 354:617-21.
13. Yudkin J, Alberti KGMM, McLarty DG, Swai ABM. Impaired glucose tolerance. Is it a risk factor for diabetes or a diagnostic ragbag? Br Med J 1990; 301:397-401.
14. Taniguchi A, Nakai Y, Doi K, Fukushima M, Nagata I, Kawamura H, et al. Glucose effectiveness in two subtypes with impaired glucose tolerance. Diabetes 1994; 43:1211-7.
15. Kanecko T, Wang PY, Tawata M, Sato A. Low carbohydrate intake before oral glucose tolerance tests. The Lancet 1998; 352:289.
16. Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Shoelson SE. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 2001; 293:1673-7.
17. Tai MM. A mathematical model for the determination of total area under glucose tolerance and other metabolic curves. Diabetes Care 1994; 17:152-4.
18. Cederholm J, Wibell L. Evaluation of insulin release and relative peripheral resistance with use of the oral glucose tolerance test. Scand J Clin Lab Invest 1985; 45:741-55.
19. Cederholm J, Wibell L. Insulin release and peripheral sensitivity at the oral glucose tolerance test. Diabetes Res Clin Pract 1990; 10:167-75.
20. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing. Diabetes Care 1999; 22:1462-70.
21. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Järvinen H, Van Harften T, et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000; 23:295-301.
22. Treskes M, Adriaansen HJ, van der Keur SJCM, Idema RN, Péquériaux N, Pronk C. Multicentre,evaluation of the EBIO plus analyzer.Eur J Clin Chem Clin Biochem 1996; 34:777-84.
23. Qualitätssicherung der quantitativen Bestimmungen im Laboratorium. Neue Richtlinien der Bundesärztekammer. Dtsch Ärzteblatt 1988; 85:B517-32.
24. Haeckel R, Brinck U, Colic D, Hänecke P, Janka HU, Püntmann I, et al. Comparability of blood glucose concentrations determined in different sample systems for detecting glucose intolerance. Clin Chem 2002; 48:936-9.
25. Passing H, Bablok W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. J Clin Chem Clin Biochem 1983; 21:709-20.
26. Bablok W, Haeckel R, Meyers W, Wosniok W. Biometrical methods In: Haeckel R, editor. Evaluation methods in laboratory medicine. Weinheim, New York: VCH Publishers, 1993:203-41.
27. Hosmer DW, Lemeshow St. Applied logistic regression. New York: John Wiley & Sons, 1889:1-307.
28. Breiman L, Friedman JH, Olshen RA, Stone CJ. Classification and regression trees. New York, London: Chapman & Hall, 1984:1-358.
29. Le Floch JP, Escuyer P, Baudin E, Baudon D, Perlemuter L. Blood glucose area under the curve: methodological aspects. Diabetes Care 1990; 13:172-5.
30. Jacob S, Rett K, Klimm HD, Ganz M, Augustin HJ, Dietze GJ. Insulinresistenz bei kardiovaskulären Risikopatientenist eine Frühdiagnostik möglich? Perfusion 1997; 10:8-14.
31. Bruns W. Zur Therapie des Typ-2-Diabetes nach Offenlegung der Ergebnisse der UKPDS-Studie. Benötigen wir eine neue Strategie? Diab Stoffwechsel 1999; 8:23-30.
32. De Fronzo RA, Ferrannini E, Koivisto V. New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus. Am J Med 1983; 74:52-81.
33. Haeckel R, Wosniok W, Puentmann I. Discordance rate, a new concept for combining diagnostic decisions with analytical performance characteristics. 1. Application in method comparison or sample system comparisons and in defining decisions limits. Clin Chem Lab Med 2003; 41:347-55.
34. Joergensen GM, Stahl M, Brandslund I, Hyltoft Petersen P, Borch-Johnsen K, De Fine Olivarius N. Plasma glucose reference interval in a low-risk population. 2. Impact of the new WHO and ADA recommendations on the diagnosis of diabetes mellitus. Scand J Clin Lab Invest 2001; 61:181-90.
35. Chien KL, Lee YT, Sung FC, Hsu HC, Su TC, Lin RS. Hyper-insulinemia and related atherosclerotic risk factors in the population at cardiovascular risk: a community-based study. Clin Chem 1999; 45:838-46.
36. Duffy Th, Phillips N, Pellegrin F. Review of glucose tolerance - a problem in methodology. Am J Med Sci 1973; 265:117-33.
37. Committee on Statistics of the American Diabetes Association. Standardization of the oral glucose tolerance test. Diabetes 1969; 18:299-310.
38. Fajans StS, Conn JW. The early recognition of diabetes mellitus. Ann NY Acad Sci 1959; 82:208-18.
39. Hayner NS, Kjelsberg MD, Epstein FH, Francis Th. Carbohydrate tolerance and diabetes in a total community, Tecumseh, Michigan. 1. Effects of age, sex, and test conditions on one hour glucose tolerance in adults. Diabetes 1965; 14:413-23.
40. Holman RR, Turner RC. The basal plasma glucose: a simple relevant index of maturity-onset diabetes. Clin Endocrinol 1980; 14:279-86.
41. Ducimetière P, Eschwege E, Papoz L, Richard JL, Claude JR, Rosselin G. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 1980; 19:205-10.
42. Sacks DB. Implementation of the revised criteria for diagnosis and classification of diabetes mellitus. Clin Chem 1997; 43:2230-2.
43. Pyorälä K, Salvolainen E, Lethovirta E, Punsar S, Siltanen P. Glucose tolerance and coronary heart disease: the Helsinki policemen study. J Cronic Dis 1979; 32:729-45.
44. Welborn TA, Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 1979; 2:154-60.
45. Greenbaum CJ, Cuthbertson D, Krischer JP. Type 1 diabetes manifested solely by 2-h oral glucose tolerance test criteria. Diabetes 2001; 50:470-6.
46. Goetz FC, French LR, Thomas W, Gingerich RL, Clements JP. Are specific serum insulin levels low in impaired glucose tolerance and type II diabetes?: measurement with a radioimmunoassay blind to proinsulin, in the population of Wadena, Minnesota. Metabolism 1995; 44:1371-6.
47. Ganda OP, Day JL, Soeldner JS, Connon JJ, Gleason RE. Reproducibility and comparative analysis of repeated intravenous and oral glucose tolerance tests. Diabetes 1978; 27:715-25.
48. Liu K, Stamler J, Stamler R, Cooper R, Shekelle RB, Schoenberger JA, et al. Methodological problems in characterizing an individual's plasma glucose level. J Chronic Dis 1982; 35:475-85.
49. Heil W, Jachtmann A, Rick W. Reproducibility of the results of the oral glucose tolerance test. Lab Med 1990; 14:440-4.
50. Schousboe K, Henriksen JE, Kyvik KO, Sörensen TIA, Hyltoft Petersen P. Reproducibility of S-insulin and B-glucose responses in two identical oral glucose tolerance tests. Scand J Clin Lab Invest 2002; 62:623-30.
51. Windeler J. Krankheitsdefinition aufgrund einer stetigen Meßgröße am Beispiel des Diabetes mellitus. Diab Stoffwechsel 1999; 8:153-8.
52. Pimenta W, Korytkowski M, Mitrakou A, Jenssen T, Yki-Jarvinen H, Evron W, et al. Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. J Am Med Assoc 1995; 273:1855-61.
53. Kosaka K, Hagura R, Kuzuya T. Insulin responses in equivocal and definite diabetes, with special reference to subjects who had mild glucose intolerance but later developed definite diabetes. Diabetes 1977; 26:944-52.
54. Efendi S, Luft R, Wajngot A. Aspects of the pathogenesis of type 2 diabetes. Endocrine Rev 1984; 5:395-410.
55. Cerasi E, Luft R. "What is inherited - what is added" hypothesis for the pathogenesis of diabetes mellitus. Diabetes 1967; 16:615-27.
56. Saad MF, Knowler C, Pettitt DJ, Nelson RG, Charles MA, Bennett PH. A two-step model for development of non-insulin-dependent diabetes. Am J Med 1991; 90:229-35.
57. Stern MP, Rosenthal M, Haffner SM. A new concept of impaired glucose tolerance: relation to cardiovascular risk. Arteriosclerosis 1985; 5:311-4.
58. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH. The natural history of impaired glucose tolerance in the Pima indians. N Engl J Med 1988; 319:1500-6.
59. Perry RC, Baron AD. Impaired glucose tolerance. Why is it not a disease? Diabetes Care 1999; 22:883-5.
60. Alberti KGMM. The clinical implications of impaired glucose tolerance. Diabetes Care 1996; 13:927-37.
61. Fraser CG. Biological variation: from principles to practice. Washington: AACC Press, 2001:1-151.
62. Galton F. Regression towards mediocrity in hereditary stature. J Anthropol Inst 1886; 15:246-63.
63. Kallner A, Waldenström J. Does the uncertainty of commonly performed glucose measurements allow identification of individuals at high risk for diabetes? Clin Chem Lab Med 1999; 37:907-12.
64. Raj D, Mohan V, Mohan R. Glycosylated hemoglobin levels and new diagnostic criteria. Diabetes Care 1998; 21:2198-9.
65. 1c levels for diagnosing diabetes. Diabetes Care 1997; 20:785-91.
66. Peters AL, Davidson MB, Schriger DL, Hasselblad V. A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. J Am Med Assoc 1996; 276:1246-52.
67. 1c. Diabetes Care 2002; 25:275-8.
68. 1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose. Diabetes Care 2001; 24:465-71.